Affinage

TEAD3

Transcriptional enhancer factor TEF-5 · UniProt Q99594

Length
435 aa
Mass
48.7 kDa
Annotated
2026-06-10
17 papers in source corpus 13 papers cited in narrative 13 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

TEAD3 is a TEA-domain transcription factor that binds GT-IIC/MCAT and SphI/SphII cis-elements to directly activate developmental and tissue-specific target genes, including the human chorionic somatomammotropin-B (hCS-B) enhancer, where it engages tandemly repeated enhansons cooperatively and is exquisitely sensitive to single-base mutations in the binding site (PMID:9148898, PMID:10379887). Its DNA-binding and transactivation output is controlled by post-translational modification: phosphorylation enhances MCAT binding under alpha1-adrenergic stimulation in cardiac myocytes (in contrast to the opposite effect seen on TEF-1) (PMID:11986313), and methylation of arginine 55 within the TEA domain restrains formation of TEAD3 homodimer condensates that otherwise spatially sequester RUNX2 to repress osteogenic differentiation (PMID:41556418). TEAD3 partners with the co-activators YAP and VGLL3, with VGLL3 engaging TEAD3 independently of the Hippo kinase cascade (PMID:31138678, PMID:31541452). Through these interactions and DNA-binding activities TEAD3 governs differentiation across multiple lineages: cardiac lineage commitment of iPSC-derived cardiovascular progenitors via YAP (PMID:31541452), trophectoderm and extravillous trophoblast programs—including YAP-independent HLA-G transcription and KRT8/KRT18/EZR-dependent blastocyst formation (PMID:40096597, PMID:39679917)—and osteoclastogenesis, where TEAD3 activates the master regulator NFATC1 and is blocked from doing so by the lncRNA MALAT1 (PMID:36993303). A covalent inhibitor targeting the TEAD3 palmitoylation pocket selectively suppresses its transcriptional activity and constrains proportional appendage growth in zebrafish (PMID:34729310).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 1997 Medium

    Established TEAD3 (hTEF-5) as a sequence-specific DNA-binding factor by showing it recognizes functional enhansons of the hCS-B enhancer, with allele-discriminating sensitivity to single-base changes.

    Evidence EMSA, enhancer-element mutagenesis, and antibody disruption of TEA-domain binding

    PMID:9148898

    Open questions at the time
    • Did not define co-activator requirements or in vivo target gene set
    • Mechanism of cooperative binding to tandem elements not resolved structurally
  2. 1999 Medium

    Connected TEAD3 DNA binding to functional output by demonstrating GT-IIC/SphI element binding and transactivation of hCS and SV40 enhancers, and showed untranslated regions modulate its expression.

    Evidence In vitro transcription/translation, EMSA, and transient reporter assays in BeWo cells

    PMID:10379887

    Open questions at the time
    • Did not identify co-activators driving transactivation
    • Element specificity (GT-IIC vs OCT) characterized in vitro only
  3. 2002 Medium

    Identified phosphorylation as a positive regulator of TEAD3 DNA binding, linking alpha1-adrenergic signaling to MCAT-driven muscle gene activation and distinguishing TEAD3 regulation from TEF-1.

    Evidence Orthophosphate labeling, IP of tagged DTEF-1, EMSA with phosphatase treatment, and reporter assays in rat cardiac myocytes

    PMID:11986313

    Open questions at the time
    • Phosphosites and responsible kinase not mapped
    • Used mouse ortholog DTEF-1; human residue conservation not addressed
  4. 2019 Medium

    Defined the co-activator landscape of TEAD3, showing VGLL3 binds TEAD3 independently of the Hippo kinase cascade while YAP couples TEAD3 to cardiac lineage commitment.

    Evidence Interaction proteomics in myoblasts/myotubes; Co-IP and RNAi phenocopy of verteporfin in iPSC cardiac differentiation

    PMID:31138678 PMID:31541452

    Open questions at the time
    • Direct target genes downstream of YAP-TEAD3 in cardiac progenitors not defined
    • VGLL3 vs YAP target-gene partitioning unresolved
  5. 2021 Medium

    Demonstrated the palmitoylation pocket is a tractable regulatory site, with a TEAD3-selective covalent inhibitor revealing a role in controlling proportional appendage growth.

    Evidence Activity-based protein profiling, GAL4-TEAD reporter assays, IC50 measurements, and zebrafish fin growth assay

    PMID:34729310

    Open questions at the time
    • Endogenous lipid modification stoichiometry and physiological regulator not defined
    • Mammalian growth-control targets not identified
  6. 2023 Medium

    Showed TEAD3 activity is gated by a non-coding RNA, with MALAT1 binding TEAD3 to block NFATC1 activation and thereby restrain osteoclast differentiation.

    Evidence RNA-protein binding assay and genetic knockout/rescue in mice with target-gene analysis (preprint)

    PMID:36993303

    Open questions at the time
    • Preprint, not yet peer-reviewed
    • Binding interface between MALAT1 and TEAD3 not mapped
  7. 2025 Medium

    Extended TEAD3's developmental roles to trophoblast biology, establishing requirement for YAP-independent HLA-G transcription in EVT and redundant control of trophectoderm fate.

    Evidence Genome-wide CRISPR-Cas9 screen in EVT cells; siRNA/base-editing dual knockdown with scRNA-seq in bovine embryos

    PMID:39679917 PMID:40096597

    Open questions at the time
    • Co-activator(s) supporting YAP-independent activation not identified
    • Direct vs indirect control of KRT8/KRT18/EZR not distinguished
  8. 2026 Medium

    Revealed arginine methylation as a switch controlling TEAD3 biophysical state, where R55 methylation limits homodimer condensate formation that otherwise sequesters RUNX2 to repress osteogenesis.

    Evidence Arginine methylation mapping, R55K mutagenesis, condensate and RUNX2 reporter assays, TEA-domain peptide sensitivity

    PMID:41556418

    Open questions at the time
    • Methyltransferase responsible for R55 not identified
    • Relationship between condensate state and canonical DNA binding not fully resolved

Open questions

Synthesis pass · forward-looking unresolved questions
  • The full set of direct TEAD3 target genes and the rules partitioning its co-activators (YAP vs VGLL3) and modifications (phosphorylation, methylation, palmitoylation) across distinct differentiation programs remain undefined.
  • No genome-wide direct binding map across tissues
  • Enzymes controlling each PTM mostly unidentified
  • Isoform-specific functions vs TEAD1/TEAD4 incompletely separated

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 5 GO:0003677 DNA binding 4
Localization
GO:0005634 nucleus 3
Pathway
R-HSA-74160 Gene expression (Transcription) 4 R-HSA-1266738 Developmental Biology 3 R-HSA-162582 Signal Transduction 3

Evidence

Reading pass · 13 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1997 hTEF-5 (TEAD3) binds to multiple functional enhansons of the human chorionic somatomammotropin-B (hCS-B) gene enhancer, including a novel tandemly repeated element to which it binds cooperatively, and the corresponding element in the inactive hCS-A enhancer is disrupted by a single base mutation that abolishes hTEF-5 binding. EMSA/DNA binding assays, mutagenesis of enhancer elements, monoclonal antibody disruption of TEA domain binding The Journal of biological chemistry Medium 9148898
1999 TEF-5 (TEAD3) protein (~53 kDa) binds specifically to GT-IIC and SphI/SphII oligonucleotides in vitro, and overexpression of TEF-5 using the intact 3033-bp cDNA (including untranslated regions) transactivates the hCS and SV40 enhancers as well as artificial tandemly repeated GT-IIC enhansons but not OCT enhansons; elements within the untranslated regions or initiation site control TEF-5 expression and influence its transactivation function. In vitro transcription/translation, EMSA, transient transfection reporter assays in BeWo cells Molecular endocrinology (Baltimore, Md.) Medium 10379887
2002 DTEF-1 (mouse ortholog of TEAD3/TEF-5) is phosphorylated in vivo, and alpha1-adrenergic stimulation increases its MCAT-binding activity and transcriptional activation of the skeletal muscle alpha-actin gene in neonatal rat cardiac myocytes; phosphatase treatment reduces MCAT binding by DTEF-1, opposite to the effect on TEF-1 itself. Orthophosphate labeling, immunoprecipitation of epitope-tagged DTEF-1, EMSA with MCAT element, chimeric TEF-1/DTEF-1 construct analysis, reporter assays The Journal of biological chemistry Medium 11986313
2019 VGLL3 physically interacts with TEAD1, TEAD3, and TEAD4 in myoblasts and/or myotubes, but unlike YAP/TAZ, VGLL3 does not interact with proteins of the Hippo kinase cascade. Interaction proteomics (co-immunoprecipitation/mass spectrometry) in myoblasts and myotubes Journal of cell science Medium 31138678
2019 YAP interacts with TEAD3 to regulate cardiac lineage commitment of human iPSCs during the cardiovascular progenitor cell stage; RNAi-mediated silencing of TEAD3 phenocopies YAP inhibitor (verteporfin) treatment, causing cells to be retained at the cardiovascular progenitor cell stage. Co-immunoprecipitation of YAP-TEAD3, RNAi knockdown of TEAD3, verteporfin pharmacological inhibition, differentiation stage marker analysis Journal of cellular physiology Medium 31541452
2021 A covalent inhibitor (DC-TEAD3in03) targeting the palmitoylation pocket of TEAD3 selectively inhibits TEAD3 transcriptional activity with >100-fold selectivity over other TEAD isoforms; TEAD3 inhibition reduces growth rate of zebrafish caudal fins, demonstrating a role for TEAD3 in controlling proportional appendage growth. Activity-based protein profiling (ABPP), GAL4-TEAD reporter assays, zebrafish fin growth assay, biochemical IC50 measurements Acta pharmaceutica sinica. B Medium 34729310
2023 MALAT1 lncRNA binds TEAD3 protein and blocks TEAD3 from binding and activating NFATC1, a master regulator of osteoclastogenesis, thereby inhibiting osteoclast differentiation; Tead3 is identified as a macrophage-osteoclast-specific TEAD family member. RNA-protein binding assay (MALAT1-Tead3 interaction), genetic knockout and rescue experiments in mice, transcriptional reporter/target gene analysis Research square (preprint)preprint Medium 36993303
2025 TEAD1 and TEAD3 are required for HLA-G transcription in extravillous trophoblasts (EVT) in a YAP-independent manner; identified by genome-wide CRISPR-Cas9 knockout screen. Genome-wide CRISPR-Cas9 knockout screen in EVT cells, validation of HLA-G expression loss Proceedings of the National Academy of Sciences of the United States of America Medium 40096597
2025 TEAD3 and TEAD4 play essential and redundant roles upstream of trophectoderm fate decisions during bovine preimplantation development; dual knockdown (TEAD3 siRNA + TEAD4 base editing) abolishes blastocyst formation and downregulates trophectoderm-specific genes KRT8, KRT18, and EZR. Single-cell RNA sequencing, RNA interference (siRNA), base editing of TEAD4, immunofluorescence, RNA sequencing Reproduction (Cambridge, England) Medium 39679917
2025 In glioblastoma, specific pharmacological inhibition of TEAD3 does not impact cell proliferation but affects sterol/cholesterol biosynthetic and metabolic processes. Pharmacological TEAD3 inhibition in patient-derived glioblastoma stem cell cultures, cell proliferation assays, pathway/metabolic analysis Brain pathology (Zurich, Switzerland) Low 40457844
2025 RhoA regulates Schwann cell microtubule dynamics and myelination via a YAP1/TEAD3/CDK2/ASPM/p60-Katanin signaling axis; TEAD3 functions downstream of YAP1 and upstream of CDK2 in this pathway. RhoA conditional knockout mice, bulk mRNA sequencing, in vitro and in vivo experiments with genetic ablation and pharmacological inhibition, CDK2 overexpression rescue Glia Low 41178531
2026 TEAD3 is methylated at arginine 55 (R55) within its DNA-binding TEA domain; disruption of R55 methylation (R55K mutation) enhances formation of TEAD3 homodimer condensates that spatially constrain RUNX2 transcriptional activity without disrupting Hippo signaling functions, thereby repressing osteogenic differentiation. Arginine methylation mapping, R55K point mutation analysis, condensate formation assays, RUNX2 activity reporter assays, TEA domain-targeting inhibitory peptide (TEAi) sensitivity assay Advanced science (Weinheim, Baden-Wurttemberg, Germany) Medium 41556418
2023 TEAD3 overexpression in prostate cancer cells inhibits proliferation and migration by suppressing ADRBK2 mRNA levels; rescue assays confirmed that ADRBK2 reverses the anti-proliferative and anti-migratory effects of TEAD3 overexpression. Overexpression of TEAD3, MTT assay, clone formation assay, scratch assay, next-generation sequencing, rescue assays with ADRBK2 Biochemical and biophysical research communications Low 36907139

Source papers

Stage 0 corpus · 17 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2019 VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle. Journal of cell science 63 31138678
1997 Human TEF-5 is preferentially expressed in placenta and binds to multiple functional elements of the human chorionic somatomammotropin-B gene enhancer. The Journal of biological chemistry 61 9148898
2021 Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3. Acta pharmaceutica Sinica. B 43 34729310
2019 YAP/TEAD3 signal mediates cardiac lineage commitment of human-induced pluripotent stem cells. Journal of cellular physiology 28 31541452
1999 Human placental TEF-5 transactivates the human chorionic somatomammotropin gene enhancer. Molecular endocrinology (Baltimore, Md.) 25 10379887
2002 Mouse DTEF-1 (ETFR-1, TEF-5) is a transcriptional activator in alpha 1-adrenergic agonist-stimulated cardiac myocytes. The Journal of biological chemistry 23 11986313
2025 TEAD3 and TEAD4 play overlapping role in bovine preimplantation development. Reproduction (Cambridge, England) 6 39679917
2025 The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts. Proceedings of the National Academy of Sciences of the United States of America 6 40096597
2023 TEAD3 inhibits the proliferation and metastasis of prostate cancer via suppressing ADRBK2. Biochemical and biophysical research communications 6 36907139
2025 Hippo pathway effectors are associated with glioma patient survival, control cell proliferation and sterol metabolism through TEAD3. Brain pathology (Zurich, Switzerland) 4 40457844
2011 Gene silencing of Tead3 abrogates radiation-induced adaptive response in cultured mouse limb bud cells. Journal of radiation research 3 21293071
2011 Molecular characterization of the porcine TEAD3 (TEF-5) gene: examination of a promoter mutation as the causal mutation of a quantitative trait loci affecting the androstenone level in boar fat. Journal of animal breeding and genetics = Zeitschrift fur Tierzuchtung und Zuchtungsbiologie 2 22775265
2025 RhoA Enhances Schwann Cell Microtubule Dynamics and Myelination via a YAP1/TEAD3/CDK2/ASPM/p60-Katanin Axis. Glia 1 41178531
2023 Long noncoding RNA Malat1 inhibits Tead3-Nfatc1-mediated osteoclastogenesis to suppress osteoporosis and bone metastasis. Research square 1 36993303
2026 Arginine Methylation Antagonizes TEAD3-Mediated Repression to Promote Osteogenic Differentiation by Disrupting RUNX2-Sequestrating Condensates. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 0 41556418
2026 Novel EWSR1::TEAD3 Fusion in an Adolescent With a Highly Aggressive Peritoneal Mesothelioma. Genes, chromosomes & cancer 0 41711168
2025 TEAD3 + high-risk melanoma cells crosstalk with GAS6 + macrophages via the GAS6-TYRO3 ligand-receptor axis to modulate propionate metabolism and drive melanoma progression. Journal of experimental & clinical cancer research : CR 0 41034991

Missed literature

Know a paper Affinage missed for TEAD3? Flag it for the maintainers and the community.

No submissions yet.